Austin, Texas — According to state and local development sources, AbbVie plans to invest $6 Million to build out 14,692 square feet of new space in Austin. The company plans to occupy the new space at 12301-A Riata Trace Pkwy, Bldg 3, Suite 100 in Austin, on or about December 1, 2025. According to the company website AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first for patients, communities, and our world. We aim to address complex health issues and enhance people’s lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need.

To learn more about AbbVie, visit http://www.abbvie.com/

Company Contact:
Robert Michael, Chief Executive Officer
847-596-8600

SOURCE: http://www.intelligence360.io
Copyright (c) 2025 SI360 Inc. All rights reserved.